GlassScriptPhysician profile
Steven D Cox
NPI 1245214303
$1,012.76
in general payments reported to CMS, 2019-2025
10 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $166 · 2022: $163 · 2024: $136 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $395.69 | 2019-2020 | |
| Orexo US, INC. | $166.94 | 2019-2020 | |
| Madrigal Pharmaceuticals | $124.52 | 2025 | Rezdiffra |
| Genzyme Corporation | $102.17 | 2024 | |
| Idorsia Pharmaceuticals US INC | $89.68 | 2022 | |
| Indivior INC. | $52.49 | 2022 | |
| Mdd US Operations, LLC | $26.48 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.60 | 2024 | Xifaxan |
| Qol Medical, LLC | $15.19 | 2024 | Sucraid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.